Transitional cell carcinoma classification: Difference between revisions
No edit summary |
No edit summary |
||
(41 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Transitional cell carcinoma}} | {{Transitional cell carcinoma}} | ||
{{CMG}} | {{CMG}};{{AE}} {{PSK}} {{RG}} | ||
==Overview== | ==Overview== | ||
Based on the growth pattern, [[transitional cell carcinoma]] may be classified into either papillary [[urothelial carcinoma]] or non-papillary [[urothelial carcinoma]]. [[Transitional cell carcinoma]] may be classified according to [[World Health Organization]] in a collaborative effort conjointly with the [[International Society of Urological Pathologists]] (ISUP) into two groups: infiltrating [[Urothelial carcinoma|urothelial carcinomas]] and non-invasive [[urothelial carcinoma]]<nowiki/>s.Based on the degree of [[cellular differentiation]][[Transitional cell carcinoma|, transitional cell carcinoma]] may be classified into two grades: low [[Grading (tumors)|grade]] and high [[Grading (tumors)|grade.]] | |||
==Classification== | |||
Based on the growth pattern, transitional cell carcinoma may be classified into two subtypes:<ref name="LederDunnick1990">{{cite journal|last1=Leder|first1=R A|last2=Dunnick|first2=N R|title=Transitional cell carcinoma of the pelvicalices and ureter.|journal=American Journal of Roentgenology|volume=155|issue=4|year=1990|pages=713–722|issn=0361-803X|doi=10.2214/ajr.155.4.2119098}}</ref> | |||
* | {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | ||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Type'''}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Description'''}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | |||
Papillary urothelial carcinoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | |||
*Slim finger-like projections that grow from the lining of the [[renal pelvis]] or [[ureter]] into the cavity | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | |||
Non-papillary urothelial carcinoma | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | |||
*Sessile or nodular tumors | |||
*They grow deeper into the layers of the wall of the [[renal pelvis]] or [[ureter]] rather than into its cavity | |||
|} | |||
===WHO Classification=== | |||
Transitional cell carcinomas may be classified according to [[World Health Organization]] in a collaborative effort conjointly with the International Society of Urological Pathologists (ISUP) into two groups: infiltrating urothelial carcinomas and non-invasive urothelial carcinomas:<ref name="pmid12461053">{{cite journal| author=Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F| title=Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 900-5 | pmid=12461053 | doi= | pmc=PMC1769816 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461053 }} </ref> | |||
{{Family tree/start}} | |||
{{familytree | | | A01 | | | A01= '''Transitional cell tumors'''}} | |||
{{familytree | |,|-|^|-|.| | }} | |||
{{familytree | B01 | | |!| | B01= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Infiltrating urothelial carcinoma'''<br> | |||
:*with squamous differentiation | |||
:*with glandular differentiation | |||
:*with trophoblastic differentiation | |||
:*Nested | |||
:*Microcystic | |||
:*Micropapillary | |||
:*Lymphoepithelioma-like | |||
:*Lymphoma-like | |||
:*Plasmacytoid | |||
:*Sarcomatoid | |||
:*Giant cell | |||
:*Undifferentiated | |||
</div>}} | |||
{{familytree | | | | | B02 | B02= <div style="float: left; text-align: left; width: 30em; padding:1em;">'''Non-invasive urothelial carcinoma''' | |||
:*Urothelial [[carcinoma in situ]] | |||
:*High grade papillary urothelial carcinoma | |||
:*Low grade papillary urothelial carcinoma | |||
:*Non-invasive papillary urothelial neoplasm of low [[malignant]] potential | |||
:*Urothelial [[papilloma]] | |||
:*Inverted urothelial papilloma | |||
</div>}} | |||
{{Family tree/end}} | |||
===Grading=== | |||
According to the [[WHO]] grading criteria, there are two grades of transitional cell carcinoma based on the degree of [[cellular differentiation]]: | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Grade'''}} | |||
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Description'''}} | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | |||
Low grade | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | |||
*Tumors with the least degree of cellular anaplasia | |||
*Rarely invades the muscular wall of the bladder or spreads to other parts of the body | |||
*Often recurs after treatment | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; align=left" | | |||
High grade | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=left | | |||
*Tumors with the most severe degrees of cellular [[anaplasia]] | |||
*Commonly recurs and also has a strong tendency to invade the muscular wall of the [[bladder]] and spread to other parts of the body | |||
*High grade transitional cell carcinoma is much more likely to result in death | |||
|} | |||
==References== | ==References== | ||
Line 18: | Line 87: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] |
Latest revision as of 03:30, 30 October 2019
Transitional cell carcinoma Microchapters |
Differentiating Transitional cell carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transitional cell carcinoma classification On the Web |
American Roentgen Ray Society Images of Transitional cell carcinoma classification |
Directions to Hospitals Treating Transitional cell carcinoma |
Risk calculators and risk factors for Transitional cell carcinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2] Ramyar Ghandriz MD[3]
Overview
Based on the growth pattern, transitional cell carcinoma may be classified into either papillary urothelial carcinoma or non-papillary urothelial carcinoma. Transitional cell carcinoma may be classified according to World Health Organization in a collaborative effort conjointly with the International Society of Urological Pathologists (ISUP) into two groups: infiltrating urothelial carcinomas and non-invasive urothelial carcinomas.Based on the degree of cellular differentiation, transitional cell carcinoma may be classified into two grades: low grade and high grade.
Classification
Based on the growth pattern, transitional cell carcinoma may be classified into two subtypes:[1]
Type | Description |
---|---|
Papillary urothelial carcinoma |
|
Non-papillary urothelial carcinoma |
|
WHO Classification
Transitional cell carcinomas may be classified according to World Health Organization in a collaborative effort conjointly with the International Society of Urological Pathologists (ISUP) into two groups: infiltrating urothelial carcinomas and non-invasive urothelial carcinomas:[2]
Transitional cell tumors | |||||||||||||||
Infiltrating urothelial carcinoma
| |||||||||||||||
Non-invasive urothelial carcinoma
| |||||||||||||||
Grading
According to the WHO grading criteria, there are two grades of transitional cell carcinoma based on the degree of cellular differentiation:
Grade | Description |
---|---|
Low grade |
|
High grade |
References
- ↑ Leder, R A; Dunnick, N R (1990). "Transitional cell carcinoma of the pelvicalices and ureter". American Journal of Roentgenology. 155 (4): 713–722. doi:10.2214/ajr.155.4.2119098. ISSN 0361-803X.
- ↑ Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, Pauwels RP, Newling DW, ten Kate F (2002). "Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems". J Clin Pathol. 55 (12): 900–5. PMC 1769816. PMID 12461053.